The sialylation of plasma lipoproteins

Atherosclerosis

Volumn 154, Issue 1, 2001, Pages 1-13

  Millar, John S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gangliosides; High density lipoprotein; Low density lipoprotein; Lp(a); Oligosaccharides; Sialic acid; Very low density lipoprotein

Indexed keywords

AMINOSUGAR; APOLIPOPROTEIN; GANGLIOSIDE; GLYCOLIPID; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; SIALIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CARBOHYDRATE ANALYSIS; CHEMICAL MODIFICATION; CORRELATION FUNCTION; DISEASE ASSOCIATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; PLASMA CLEARANCE; PRIORITY JOURNAL; REVIEW; SIALYLATION; SOLUBILITY;

ANIMALS; APOLIPOPROTEINS; GLYCOLIPIDS; HUMANS; LIPOPROTEINS; N-ACETYLNEURAMINIC ACID;

EID: 0035203845     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00697-3     Document Type: Review

References (107)

1. Chemistry and biochemistry of sialic acids
2. Glycoproteins: What are the sugar chains for?
3. 3 is recognized by Cancer antennarius lectin
4. Measurement of sialic acid in serum and urine: Clinical applications and limitations
5. Occurrence of sialic acids in healthy humans and different disorders
6. Relationship between immunoinflammatory proteins containing sialic acid and low-density lipoprotein serum concentrations
7. Serum sialic acid concentration and cardiovascular mortality
8. Serum sialic acid as an indicator of change in coronary artery disease
9. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound
10. LDL sialic acid content in patients with coronary artery disease
11. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated with altered cellular metabolism in the blood of atherosclerotic patients
12. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease
13. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans
14. Physicochemical properties of apolipoprotein(a) and lipoprotein(a) derived from the dissociation of human plasma lipoprotein (a)
15. Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)
16. Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms
17. Human small-intestinal apolipoprotein B-48 oligosaccharide chains
18. The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoprotein
19. The structure of the asparagine-linked sugar chains of human apo B-100
20. Human preproapolipoprotein C-II. Analysis of major plasma isoforms
21. Characterization of the oligosaccharide side chains of apolipoprotein C-III from human plasma
22. Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma
23. The carbohydrate content of apolipoprotein E from human very low density lipoproteins
24. Intracellular processing of apolipoprotein J precursor to the mature heterodimer
25. Identification, characterization, cloning, and expression of apolipoprotein C-IV, a novel sialoglycoprotein of rabbit plasma lipoproteins
26. Qualitative analysis of the carbohydrate composition of apolipoprotein H
27. A novel human apolipoprotein
28. 0 lacks carbohydrate residues: Use of mass spectrometry to study apolipoprotein structure
29. Glycosylation of human apolipoprotein E
30. Two-dimensional electrophoresis of human plasma apolipoproteins
31. Analysis of glycoprotein-associated oligosaccharides
32. O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins
33. All low density lipoprotein particles are partially desialylated in plasma
34. Fluorometric detection of glycosphingolipids on thin-layer chromatographic plates
35. Relation of N-glycosylation of apolipoprotein B-100 to cellular metabolism of low density lipoprotein
36. Heterogeneity of N-linked sugar chains of apolipoprotein B-100 in Watanabe heritable hyperlipidemic and fasting rabbits
37. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome
38. Carbohydrate-deficient transferrin and gamma-glutamyltransferase are inversely associated with lipid markers of cardiovascular risk
39. Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma
40. The complete amino acid sequence of alanine apolipoprotein, (apo C-III), an apolipoprotein from human plasma very low density lipoproteins
41. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III
42. Effect of desialylation of very low-density lipoproteins on their catabolism by lipoprotein lipase
43. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor
44. Activation of lipoprotein lipase by apolipoprotein C-II is modulated by the COOH terminal region of apolipoprotein C-III
45. Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels
46. Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin: Cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion
47. Plasma catabolism of human apolipoprotein E isoforms: Lack of conversion of the doubly sialylated form to the asialo form
48. Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver
49. Effect of chronic ethanol on apolipoprotein (Apo) E synthesis and glycosylation in rats
50. Long-term ethanol exposure alters the sialylation index of plasma apolipoprotein J (Apo J) in rats
51. Apolipoprotein(a): Expression and characterization of a recombinant form of the protein in mammalian cells
52. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": The role of kringle IV sequences in the exracellular association with low-density lipoprotein
53. Effect of desialylation on the biological properties of human plasminogen
54. The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation
55. The gangliosides
56. Biosynthesis and excretion of gangliosides by the isolated perfused rat liver
57. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins
58. Distribution of exogenously added gangliosides in serum proteins depends on the relative affinity of albumin and lipoproteins
59. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells
60. Molecular cloning and functional analysis of sialyltransferases
61. Sialic-acid content of low-density lipoproteins controls their binding and uptake by cultured cells
62. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions
63. Cholesterol transfer between lipid vesicles. Effect of phospholipids and gangliosides
64. Optimization of the assay for sialic acid determination in low density lipoprotein
65. Intracellular modification of human apolipoprotein E
66. Biochemical and genetic studies of the apolipoprotein E secreted by mouse macrophages and human monocytes
67. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
68. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B
69. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins
70. Introduction to lipoproteins
71. Protein polymorphism of a human plasma apolipoprotein D antigenic epitope
72. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III
73. Spontaneous and plasma factor-mediated transfer of pyrenyl cerebrosides between model and native lipoproteins
74. Synthesis, intracellular processing, and signal pepticle of human apolipoprotein E
75. Desialylated low density lipoprotein-naturally occurring modified lipoprotein with atherogenic potency
76. Demonstration of neuraminidase activity in human blood serum and human milk using a modified radioactively labeled 1-glycoprotein as substrate
77. Plasma sialidase activity in acute myocardial infarction
78. Increase in plasma neuraminidase activity in experimental peritonitis
79. Apoprotein C catabolism in man
80. Effect of sialic acid removal on human low density lipoprotein catabolism in vivo
81. Unaltered catabolism of desialylated low-density lipoprotein in the pig and in cultured rat hepatocytes
82. Bovine transferrin glycopeptide: The relevance of its structure with the mammalian hepatic lectin that binds asialoglycoproteins
83. The role of sialic acid in determining the survival of glycoproteins in the circulation
84. Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor
85. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification
86. Possible involvement of radical reactions in desialylation of LDL
87. Studies on the chemical and enzymatic modification of glycoproteins
88. The thiobarbituric acid assay of sialic acids
89. Quantitative estimation of sialic acids
90. Characterization of human plasma sialyltransferase using a novel fluorometric assay
91. Human very low density lipoproteins: Loss of electrophoretic mobility on enzymatic removal of sialic acid residues
92. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia
93. Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content
94. Charge heterogeneity of LDL in asymptomatic hypercholesterolemic men is related to lipid parameters and variations in the ApoB and C-III genes
95. The effect of fasting on the interactions between human low density lipoproteins and calcium, heparin and chondroitin sulfate
96. Effect of lipoprotein(a) on lipid metabolism of cultured human intimal aortic cells
97. Role of the carbohydrate moiety in the antigenic site(s) of human serum low-density lipoprotein
98. The absence of a role for the carbohydrate moiety in the binding of apolipoprotein B to the low density lipoprotein receptor
99. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor
100. Rat natural killer cell antigen, NKR-P1, related to C-type animal lectins is a carbohydrate-binding protein
101. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization
102. Isolation and characterization of the two major apoproteins in human lipoprotein(a)
103. Evaluation of the efficiency of an assay procedure for gangliosides in human serum
104. Extraction and purification of gangliosides from plasma and fibroblasts before analysis by thin layer chromatography
105. A 70-kDa apolipoprotein designated apoJ is a marker for subclasses of human plasma high density lipoproteins
106. Heterogeneity of lipoprotein (a): Growing complexities